Copyright 2014 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
Colorectal cancer (CRC) is a leading cause of cancer death in the United States. Many CRC deaths could be averted by screening because screening decreases both CRC incidence and mortality by 30% to 60%.1 Although CRC screening rates have risen in recent years, with 65% of Americans aged 50 to 75 years reporting being up-to-date,2 rates remain suboptimal and are marked by pronounced racial/ethnic and socioeconomic disparities. Only 53% of Latinos2 and 39% of individuals with incomes below the federal poverty level are current for CRC screening (Figure). Low socioeconomic status is also associated with higher rates of CRC mortality.3 Increasing screening in priority populations could substantially decrease morbidity and mortality from CRC.
Green BB, Coronado GD. “BeneFITs” to Increase Colorectal Cancer Screening in Priority Populations. JAMA Intern Med. 2014;174(8):1242–1243. doi:10.1001/jamainternmed.2014.730
Customize your JAMA Network experience by selecting one or more topics from the list below.